Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders
申请人:Desmadryl Gilles
公开号:US20120039913A1
公开(公告)日:2012-02-16
The invention relates to Histamine H4 receptor antagonists or inhibitors of Histamine H4 receptor gene expression for the treatment and/or the prevention of vestibular disorders.
该发明涉及
组胺H4受体拮抗剂或
组胺H4受体
基因表达
抑制剂,用于治疗和/或预防前庭障碍。